These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3496680)

  • 1. The interaction of activated protein C and thrombin with the plasminogen activator inhibitor released from human endothelial cells.
    de Fouw NJ; van Hinsbergh VW; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):176-82. PubMed ID: 3496680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activated protein C increases fibrin clot lysis by neutralization of plasminogen activator inhibitor--no evidence for a cofactor role of protein S.
    de Fouw NJ; de Jong YF; Haverkate F; Bertina RM
    Thromb Haemost; 1988 Oct; 60(2):328-33. PubMed ID: 2975409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of activated protein C in facilitating basement membrane invasion by tumor cells.
    Kobayashi H; Moniwa N; Gotoh J; Sugimura M; Terao T
    Cancer Res; 1994 Jan; 54(1):261-7. PubMed ID: 8261450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
    Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
    Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.
    Gresele P; Momi S; Berrettini M; Nenci GG; Schwarz HP; Semeraro N; Colucci M
    J Clin Invest; 1998 Feb; 101(3):667-76. PubMed ID: 9449701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-gamma inhibits thrombin- and endotoxin-induced plasminogen activator inhibitor type 1 in human endothelial cells.
    Gallicchio M; Hufnagl P; Wojta J; Tipping P
    J Immunol; 1996 Sep; 157(6):2610-7. PubMed ID: 8805664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lupus anticoagulant on antithrombogenic properties of endothelial cells--inhibition of thrombomodulin-dependent protein C activation.
    Cariou R; Tobelem G; Bellucci S; Soria J; Soria C; Maclouf J; Caen J
    Thromb Haemost; 1988 Aug; 60(1):54-8. PubMed ID: 2847352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells.
    Van Hinsbergh VW; Sprengers ED; Kooistra T
    Thromb Haemost; 1987 Apr; 57(2):148-53. PubMed ID: 3496679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
    Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
    Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of protein C in endotoxin-induced release of plasminogen activator inhibitor from endothelial cell].
    Okajima K; Koga S; Nakagaki T; Okabe H; Funatsu A; Takatsuki K
    Nihon Ketsueki Gakkai Zasshi; 1989 Nov; 52(7):1159-64. PubMed ID: 2618561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An enzyme-linked immunosorbent assay (ELISA) used to study the cellular secretion of endothelial plasminogen activator inhibitor (PAI-1).
    MacGregor IR; Booth NA
    Thromb Haemost; 1988 Feb; 59(1):68-72. PubMed ID: 3129808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein S is a cofactor for activated protein C neutralization of an inhibitor of plasminogen activation released from platelets.
    D'Angelo A; Lockhart MS; D'Angelo SV; Taylor FB
    Blood; 1987 Jan; 69(1):231-7. PubMed ID: 2947643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cathepsin G--induced release of PAI-1 in the culture medium of endothelial cells: a new thrombogenic role for polymorphonuclear leukocytes?
    Pintucci G; Iacoviello L; Castelli MP; Amore C; Evangelista V; Cerletti C; Donati MB
    J Lab Clin Med; 1993 Jul; 122(1):69-79. PubMed ID: 8320493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redirection of the reaction between activated protein C and a serpin to the substrate pathway.
    Komissarov AA; Andreasen PA; Declerck PJ; Kamikubo Y; Zhou A; Gruber A
    Thromb Res; 2008; 122(3):397-404. PubMed ID: 18045665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Less pronounced enhancement of thrombin-dependent inactivation of plasminogen activator inhibitor type 1 by low molecular weight heparin compared with unfractionated heparin.
    Nakamura R; Umemura K; Hashimmoto H; Urano T
    Thromb Haemost; 2006 Apr; 95(4):637-42. PubMed ID: 16601834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.
    van Hinsbergh VW; Bertina RM; van Wijngaarden A; van Tilburg NH; Emeis JJ; Haverkate F
    Blood; 1985 Feb; 65(2):444-51. PubMed ID: 3917696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultured human mesangial cells produce both type 1 and type 2 plasminogen activator inhibitors.
    Colucci M; Gesualdo L; Montemurro P; Cavallo LG; Conese M; Mascolo E; Ranieri E; Di Paolo S; Schena FP; Semeraro N
    Thromb Haemost; 1995 Dec; 74(6):1516-20. PubMed ID: 8772230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein C and its inhibitor in malignancy.
    Suzuki K; Hayashi T
    Semin Thromb Hemost; 2007 Oct; 33(7):667-72. PubMed ID: 18000793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
    Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
    Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.